Cantor Fitzgerald Reaffirms Neutral Rating for Acadia Healthcare (NASDAQ:ACHC)

Cantor Fitzgerald restated their neutral rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a report published on Tuesday morning,Benzinga reports. Cantor Fitzgerald currently has a $52.00 price objective on the stock.

Other analysts have also issued reports about the company. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, November 22nd. Barclays dropped their price objective on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $75.44.

Acadia Healthcare Price Performance

Shares of ACHC opened at $39.87 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company’s fifty day moving average price is $46.39 and its 200-day moving average price is $62.29. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77. The firm has a market capitalization of $3.70 billion, a PE ratio of 13.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.30.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same quarter in the previous year, the business earned $0.91 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Large investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 12.2% during the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. William Blair Investment Management LLC boosted its holdings in Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after buying an additional 604,070 shares during the last quarter. State Street Corp increased its stake in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Acadia Healthcare by 0.5% during the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock valued at $144,753,000 after acquiring an additional 12,470 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of Acadia Healthcare by 0.9% in the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company’s stock valued at $102,320,000 after acquiring an additional 14,197 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.